Skip to content

Percutaneous Coronary Angioplasty Compared With Exercise Training in Symptomatic Coronary Artery Disease

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00176358
Enrollment
400
Registered
2005-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2007-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CAD, Stable Angina Pectoris

Brief summary

The purpose of this study is to compare coronary angioplasty with stent implantation with an exercise rehabilitation program in patients with stable coronary artery disease (CAD).

Interventions

DEVICEPTCA and Stent Implantation
BEHAVIORALExercise Training

Sponsors

University of Leipzig
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Angiographically documented CAD, with at least one coronary artery stenosis of more than 50% in a native segment never subjected to intervention, which is recommended for treatment with percutaneous transluminal coronary angioplasty (PTCA). * Stable coronary artery disease * Eligible patients could be asymptomatic or have class I to III angina (Canadian Cardiovascular Society \[CCS\]) with documented myocardial ischemia * Angina pectoris threshold \> 50 Watt (cycle ergometry) * Permanent residence should be within 25 km of training facility.

Exclusion criteria

* \< 18 or \> 70 years of age * Patient currently participating in an exercise training program * Unstable angina pectoris or myocardial infarction during the last 2 weeks * Symptoms of CCS class IV * Exercise limitations due to clinical conditions not related to CAD * Left ventricular ejection fraction (LVEF) of \< 40% * Ventricular arrhythmia (Lown Ivb) * Hemodynamically significant valvular heart disease * Previous cardiac surgery * PTCA performed during the last 12 months * Any major non-cardiac condition that would adversely affect survival during the duration of the study * Reduced compliance

Countries

Germany

Contacts

Primary ContactRainer Hambrecht, Prof.
rhambrecht@medizin.uni-leipzig.de00493418651426

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026